Skip to main content

Clinical Reviews in Allergy & Immunology

Ausgabe 1/2017

The Anti-Phospholipid Syndrome and Other Cutting Edge Issues in Inflammation

Inhalt (11 Artikel)

Anti-phospholipid Antibodies and Smoking: An Overview

Steven R. Binder, Christine M. Litwin

Lymphocyte Disturbances in Primary Antiphospholipid Syndrome and Application to Venous Thromboembolism Follow-Up

Laurent Simonin, Elisabeth Pasquier, Christophe Leroyer, Divi Cornec, Julie Lemerle, Boutahar Bendaoud, Sophie Hillion, Jacques-Olivier Pers, Francis Couturaud, Yves Renaudineau

Additional Treatments for High-Risk Obstetric Antiphospholipid Syndrome: a Comprehensive Review

Amelia Ruffatti, Ariela Hoxha, Maria Favaro, Marta Tonello, Anna Colpo, Umberto Cucchini, Alessandra Banzato, Vittorio Pengo

Tumor Necrosis Factor-Alpha and Pregnancy: Focus on Biologics. An Updated and Comprehensive Review

Jaume Alijotas-Reig, Enrique Esteve-Valverde, Raquel Ferrer-Oliveras, Elisa Llurba, Josep Maria Gris

Female Infertility and Serum Auto-antibodies: a Systematic Review

Alban Deroux, Chantal Dumestre-Perard, Camille Dunand-Faure, Laurence Bouillet, Pascale Hoffmann

Open Access

Next-Generation Autoantibody Testing by Combination of Screening and Confirmation—the CytoBead® Technology

Mandy Sowa, Rico Hiemann, Peter Schierack, Dirk Reinhold, Karsten Conrad, Dirk Roggenbuck

A Critical Evaluation of Liver Pathology in Humans with Danon Disease and Experimental Correlates in a Rat Model of LAMP-2 Deficiency

Lu Wang, Jingbo Wang, Weile Cai, Yongquan Shi, Xinmin Zhou, Guanya Guo, Changcun Guo, Xiaofeng Huang, Zheyi Han, Shuai Zhang, Shuoyi Ma, Xia Zhou, Daiming Fan, M. Eric Gershwin, Ying Han

Air Travel, Circadian Rhythms/Hormones, and Autoimmunity

J. Torres-Ruiz, A. Sulli, M. Cutolo, Y. Shoenfeld

Autoimmunity in 2016

Carlo Selmi

Aktuelle Ausgaben

Scrollen für mehr

Benutzen Sie die Pfeiltasten für mehr

Scrollen oder Pfeiltasten für mehr

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.